Lilly to cut insulin prices by 70%, cap costs at $35 per month for people with private insurance
Publishing timestamp: 2023-03-01 14:01:04
Summary
Eli Lilly & Co. announced that it will cut prices of its most commonly prescribed insulins by 70% and cap monthly out-of-pocket costs at $35 at certain retail pharmacies for people who have private insurance. The announcement comes amid growing federal pressure to lower insulin prices. President Joe Biden applauded Lilly's decision and called on other drugmakers to follow suit.
Sentiment: POSITIVE
Tickers: LLY,
Keywords: business news, biotech and pharmaceuticals, eli lilly and co, politics, joe biden, coronavirus, epidemics, business, breaking news: business, biotechnology, pandemics, health care industry, u.s. economy, disease outbreaks,